Concepedia

Kerri Lipinski

KL

7

Publications

291

Citations

7

H-Index

2005

Active since

Affiliations

Princeton University(Current)

Pfizer (United States)

Kerri Lipinski is an author at Princeton University specializing in medicine, drug discovery, and natural sciences.

Top concepts

MedicineDrug DiscoveryPharmacologyNatural SciencesMolecular BiologyBiochemistryCell BiologyCell SignalingMedicinal ChemistrySignal Transduction

Publications per year

2005–2016

7

Publications

7

Investigation of leucine‐rich repeat kinase 2

Vasanti S. Anand, Laurie J. Reichling, Kerri Lipinski et al. · FEBS Journal · 2008 · 112 citations

Mitophagy, Immunology, Leucine‐rich Repeat +16

Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif

Pooja Pungaliya, Yuchen Bai, Kerri Lipinski et al. · PLoS ONE · 2010 · 71 citations · Full text

Molecular Biology, Signaling Pathway, Cell Regulation +17

Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors

Andrew F. Donnell, Paul Dollings, John A. Butera et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 39 citations · Full text

Medicinal Chemistry, Medicine, Heterocycle Chemistry +3

Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist

Ya‐Jun Zheng, Linghang Zhuang, Kristi Fan et al. · Journal of Medicinal Chemistry · 2016 · 32 citations · Full text

Crystal Structure, Drug Target, Molecular Biology +23

Disruption of ShcA signaling halts cell proliferation — characterization of ShcC residues that influence signaling pathways using yeast

Julia Heinrich, Seung Kwak, David Howland et al. · Cellular Signalling · 2005 · 15 citations

Signal Transduction, Cell Regulation, Cell Division +14

Rows per page

1–5 of 7